Skip to main content
. 2010 Apr;82(4):529–534. doi: 10.4269/ajtmh.2010.09-0334

Figure 1.

Figure 1.

Schematic representation of inclusion criteria for the analysis of parasitological treatment failures (A) and clinical failures (B). regular 8-weekly follow-up bleed; ◆ clinical episode sample; Inline graphic treatment with Coartem®; ▲ FUB sample PCR positive for recrudescent allele; Δ FUB sample PCR negative for recrudescent allele.